» Articles » PMID: 18442507

Evidence-based Practice Recommendations for Nutrition-related Management of Children and Adults with Cystic Fibrosis and Pancreatic Insufficiency: Results of a Systematic Review

Overview
Journal J Am Diet Assoc
Publisher Elsevier
Date 2008 Apr 30
PMID 18442507
Citations 198
Authors
Affiliations
Soon will be listed here.
Abstract

The Cystic Fibrosis Foundation established a process of systematic review of evidence to inform the development of clinical care guidelines and encourage evidence-based practice. The Subcommittee on Growth and Nutrition reviewed the evidence in two areas: energy intake and dosing for pancreatic enzyme replacement therapy. Evidence-based recommendations are presented here. Also, an ad hoc working group conducted a review of the literature and performed new analyses using the Cystic Fibrosis Foundation Patient Registry to update the recommendations for growth and weight-status monitoring. These Registry data-based recommendations are presented.

Citing Articles

Glucagon-like peptide1 receptor agonist treatment of cystic fibrosis-related diabetes complicated by obesity: A cases series and literature review.

Ahmed A, Ankireddypalli A, Harindhanavudhi T, Moran A, Moheet A J Clin Transl Endocrinol. 2025; 38:100375.

PMID: 39764279 PMC: 11702000. DOI: 10.1016/j.jcte.2024.100375.


How Do Early Weight Trajectories Explain Social Inequalities in Lung Function in Children With Cystic Fibrosis?: A Longitudinal Interventional Disparity Effects Analysis With Time-varying Mediators and Intermediate Confounders.

Schluter D, Keogh R, Daniel R, Agbla S, Taylor-Robinson D Epidemiology. 2025; 36(2):275-285.

PMID: 39760864 PMC: 11774196. DOI: 10.1097/EDE.0000000000001826.


Low-added sugar dietary intervention study to mitigate glucose intolerance and improve body composition in adults with cystic fibrosis: a protocol of a double-blind, randomised study.

Zaveri S, Stecenko A, Hunt W, Goss A, Sharma P, Hartman T BMJ Open. 2024; 14(12):e092503.

PMID: 39725418 PMC: 11683900. DOI: 10.1136/bmjopen-2024-092503.


Pilot and feasibility study of dietary composition with elexacaftor-tezacaftor-ivacaftor concentrations in people with cystic fibrosis.

Rose N, Bailey J, Anderson J, Chalamalla A, Ryan K, Acosta E Pharmacotherapy. 2024; 44(12):920-926.

PMID: 39716404 PMC: 11834086. DOI: 10.1002/phar.4630.


Edinburgh postnatal depression scale score elevation in caregivers of infants with cystic fibrosis.

Gillespie M, Jayaram S, Eisner M, Sliemers S, Pasley K, McCoy K Pediatr Pulmonol. 2024; 60(1):e27364.

PMID: 39469979 PMC: 11740653. DOI: 10.1002/ppul.27364.